MegaMD Co. Ltd (133750) — Capital Reinvestment Ratio
Latest as of June 2025:
0.06x
MegaMD Co. Ltd (133750) has a Capital Reinvestment Ratio of 0.06x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩2.56 Billion) in capital expenditures (₩161.10 Million). See MegaMD Co. Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
₩2.56 Billion
KRW
Capital Expenditures
₩161.10 Million
KRW
Data as of
Jun 2025
Most recent filing
MegaMD Co. Ltd Capital Reinvestment Ratio (2014–2025)
This chart tracks MegaMD Co. Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for MegaMD Co. Ltd (2014–2025)
Year-by-year Capital Reinvestment Ratio for MegaMD Co. Ltd from 2014 to 2025. For live market cap and broader valuation context, see MegaMD Co. Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.26x | ₩5.10 Billion | ₩1.33 Billion | ▲ +658.6% |
| 2024 | 0.03x | ₩8.39 Billion | ₩288.61 Million | ▼ -98.5% |
| 2023 | 2.35x | ₩1.05 Billion | ₩2.48 Billion | ▲ +1882.2% |
| 2021 | 0.12x | ₩17.94 Billion | ₩2.13 Billion | ▼ -12.0% |
| 2020 | 0.13x | ₩16.03 Billion | ₩2.16 Billion | ▼ -12.6% |
| 2019 | 0.15x | ₩9.69 Billion | ₩1.50 Billion | ▲ +5.3% |
| 2018 | 0.15x | ₩14.97 Billion | ₩2.20 Billion | ▼ -70.2% |
| 2017 | 0.49x | ₩7.60 Billion | ₩3.74 Billion | ▼ -77.3% |
| 2016 | 2.16x | ₩5.01 Billion | ₩10.82 Billion | ▲ +646.6% |
| 2015 | 0.29x | ₩18.12 Billion | ₩5.25 Billion | ▼ -35.6% |
| 2014 | 0.45x | ₩7.53 Billion | ₩3.38 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow